pirations were 18 breaths per minute, with an oxygen saturation of 100% in room air. The patient reported 10 of 10 pain in her throat. Upon examination, she appeared ill and in moderate distress, but she was alert and had no neurological deficits or confusion. Pharyngeal examination revealed erythema with grade 3 tonsil hypertrophy without exudates and dry mucous membranes. Neck was tender upon palpation, with bilateral anterior cervical lymphadenopathy (right greater than left). Lungs were clear upon bilateral auscultation, but there were slightly diminished breath sounds diffusely. Heart auscultation revealed a tachycardic, regular rhythm without any murmur. Abdominal examination revealed a soft, nondistended abdomen that had mild diffuse tenderness with normal bowel sounds. A radial pulse deficit was noted, along with normal capillary refill, no peripheral edema, and no skin rashes.
The overall clinical presentation was a patient showing signs of sepsis following failed outpatient treatment of pharyngitis and tonsillitis. Despite aggressive fluid resuscitation with 3 L of normal saline, the patient remained hypotensive and tachycardic, with a blood pressure and pulse in the range of 80 -90/50 -70 mmHg and 100 -120 beats per minute, respectively. Fever, pain, nausea, and vomiting were treated symptomatically.
The initial laboratory workup in the ED included a complete metabolic panel, complete blood count , lipase, urine pregnancy test, rapid group A streptococcus pharyngeal swab, heterophile antibody screen for mononucleosis, urinalysis, microscopic urine examination, chest radiograph, and 2 blood cultures. Results were consistent with hypovolemia and a stress response. She had leukocytosis with a left shift, mild hyperglycemia, mild thrombocytopenia, and mild hyperbilirubinemia. Lipase, group A streptococcus swab, heterophile antibody screen, urine pregnancy test, and chest radiograph were all negative.
Hospital Course
The patient was admitted to the hospital and started on empiric antibiotic treatment with intravenous (IV) ceftriaxone (1 g every 24 hours). A respiratory virus panel was added to the initial lab work. Aggressive fluid hydration was continued as the patient continued to demonstrate a septic clinical picture.
On the second hospital day, antibiotic coverage was broadened in response to an increasing white blood cell count, as shown in Figure 1 , which highlights pertinent lab trends and points of key medication changes during the hospital course. Clindamycin (600 mg IV every 8 hours) was added for anaerobic coverage (shown as the orange dashed line in Figure  1 ). Over the next 2 days, test results gradually showed improvement of white blood count, neutrophil count, and C-reactive protein concentration. The patient began to tolerate oral intake and was switched to oral cefdinir (300 mg twice daily) and clindamycin (300 mg every 8 hours).
Despite the improvement in lab values, she began to develop worsening right-sided neck pain with increased swelling, warmth, induration, and mild trismus. Strep cultures were negative and the respiratory virus panel was positive for a concurrent rhinovirus infection. On the fourth hospital day, 1 of 2 blood cultures were positive for gram-negative rods. Her right neck swelling continued to worsen, and on the fifth hospital day, computed tomography (CT) of the neck and soft tissues with and without IV contrast was ordered to evaluate for a possible abscess. CT revealed complete occlusion of the right IJ vein, extending from just inferior to the IJ foramen to the lower neck, with associated retropharyngeal edema ( Figure 2 ). There was a question of whether the hypodense area in the retropharyngeal space represented edema or an abscess ( Figure 2C ). On the fifth hospital day, the initial blood cultures identified an anaerobic organism, Fusobacterium nucleatum, making the diagnosis of Lemierre syndrome and a septic thrombus the most likely cause of the patient's clinical condition. An infectious disease specialist and an ear, nose, and throat surgeon were consulted. Blood cultures were repeated, and antibiotic coverage was broadened to vancomycin (1 g IV loading dose, then 750 mg IV every 8 hours), metronidazole (500 mg IV every 8 hours), and high-dose ceftriaxone (2 g IV every 24 hours). Because of the risk of septic emboli, increasing symptoms of dyspnea, dry cough, and the incidental finding of bilateral pleural effusions on the initial CT of the neck, a CT angiogram of the chest was ordered to rule out septic pulmonary emboli. The CT angiogram was negative for septic pulmonary emboli but did show moderate-sized bilateral pleural effusions with atelectasis, as shown in Figure 3 . This patient's case is unique in that she never appeared as ill as her condition and the objective findings, including imaging, suggested. By the second hospital day, the patient's sepsis had seemed to resolve with the initial antibiotic treatment and fluid resuscitation. In this clinically stable patient, the risks of attempting to drain the retropharyngeal space seemed to outweigh the benefits, and the patient was placed on a dexamethasone steroid taper (15, 12, 8 , and 4 mg, once each, every 24 hours; dotted black line in Figure 1) , with significant improvement in clinical symptoms.
Vascular surgery also was consulted, and the patient was started on anticoagulation with enoxaparin (1.5 mg/kg subcutaneously once daily), bridging to warfarin (5 mg daily) on the fifth hospital day. Vancomycin was discontinued on hospital day 6, and the patient was switched to oral metronidazole. She was discharged from the hospital on hospital day 7 on outpatient IV ceftriaxone (2 g once daily) and metronidazole (500 mg by mouth every 8 hours). Following discharge, culture sensitivities for F. nucleatum came back pan-sensitive to cefotetan, clindamycin, metronidazole, and piperacillin-tazobactam. Follow-up lab values 12 days from admission showed continued improvement ( Figure  1 ). The patient received 2 weeks of IV ceftriaxone before switching to cefpodoxime (400 mg by mouth twice daily). She continued cefpodoxime and metronidazole for 4 additional weeks. Anticoagulation was continued for a total of 3 months of therapy.
Case Discussion
Background Sore Throat is a common presenting complaint in the outpatient setting. 1 Most cases are nonbacterial in origin, the others are usually caused by group A eta-hemolytic Streptococcus. 2 Guidelines exist to help physicians decide whether or not to treat with an antibiotic. 3 Lemierre syndrome is an exceedingly rare condition characterized by septic thrombophlebitis of the IJ vein. 4 It also has been referred to as postanginal necrobacillosis and, more recently, as the "forgotten disease." 5 The course of the disease generally starts with a localized oropharyngeal infection, which spreads to involve the lateral pharyngeal space and then the structures of the carotid sheath, eventually causing septic thrombosis of the IJ vein. 4, 6, 7 The most commonly identified pathogens are bacteria from the Fusobacterium genus, specifically F. necrophorum, which are normal flora within the genitourinary tract, gastrointestinal tract, and oropharynx. 4 The first report was published by Andre Lemierre in 1936. 7 While F. necrophorum is the most commonly isolated pathogen, multiple other bacteria have been implicated, including other Fusobacterium, Eikenella, Bacterioides, Streptococcus, Peptostreptococcus, Staphylococcus, Porphyromonas, Prevotella, and Proteus spp. Antecedent viral infections also have been associated with this syndrome, including associations with the Epstein-Barr virus. Variants of Lemierre syndrome have been reported, but the discussion here focuses primarily on septic thrombosis of the IJ vein. 8 The incidence of Lemierre syndrome is extremely rare, with about 0.8 to 1.5 cases per million people annually. 5 There are some reports of increasing incidence in the recent past, but these have not been shown to be significant; case clusters also have been reported. 9 It is a disease of the young; most cases occur in individuals ages 14 to 24 years old, with a mean age of 20 years. Other than age and oropharyngeal infection, few risk factors have been clearly identified, although some cases have been associated with a diagnosis of concurrent thrombophilias. 10 As mentioned previously, Lemierre syndrome generally begins as a localized oropharyngeal infection in the palatine tonsil or peritonsillar tissues. Dental, ear, sinus, and glandular sites are rarer sources of primary infection. 4 The time interval from primary infection to septic thrombophlebitis is generally 1 to 3 weeks, and mortality occurs in about 5%. 11 The exact mechanism is unknown but has been postulated as either hematogenous, local, or via lymphatics.
Diagnosis
In his initial article, Lemierre 7 described a syndrome of pyrexial attacks, chills, pulmonary infarcts, and arthritic symptoms several days following an oropharyngeal infection. The diagnosis is often missed until a gram-negative rod is identified in culture. 4 Patients commonly present with sore throat, neck pain, trismus, fevers, and chills. Upon examination, they classically have increasing asym- metric swelling of the neck area overlying the sternocleidomastoid muscle at the angle of the mandible, with associated warmth or induration. However, they can also appear to be septic without any localizing pharyngeal symptoms because the antecedent infection sometimes resolves before presentation. These localized signs and symptoms can be absent or missed during examination.
A high index of suspicion is necessary for a diagnosis of Lemierre syndrome. Clinical signs and symptoms indicating the diagnosis can be few and subtle. In the aforementioned case, the lack of resolution over the expected time frame with ordinary intervention lent itself to the need for a broadened differential diagnosis. Failed treatment, worsening symptoms, or no improvement after 5 days should increase the physician's index of suspicion. 12 Because Fusobacterium is an anaerobe, blood cultures can take 2 to 7 days 13 to return positive for infection, further delaying the diagnosis. Prompt diagnosis and initiation of appropriate therapy is crucial in reducing adverse outcomes and significant complications of the disease. There is no mention of the earliest point when imaging is expected to become abnormal, but consideration of the disease and consistent symptoms should prompt confirmation with contrast-enhanced CT of the neck sooner than later. An earlier CT would have sped up the confirmation of our case.
Management
Like all infections, the optimal antibiotic regimen depends on the source of infection. Initial management should include coverage with broad-spectrum antibiotics. A ␤-lactamase-resistant penicillin and an antibiotic with good anaerobic coverage should be included in empiric therapy because of the increasing prevalence of ␤-lactamase-producing pathogens. Some Fusobacterium strains are resistant to penicillin.
14 Acceptable antibiotic regimens include high-dose ceftriaxone along with metronidazole or clindamycin monotherapy. 15 Vancomycin can be added if suspicion or prevalence of methicillin-resistant Staphylococcus aureus is high.
The optimal duration of therapy is uncertain. Most patients generally require at least 2 to 4 weeks of IV antibiotic therapy followed by another 2 to 4 weeks of oral antibiotics. 16 Duration of therapy is usually guided by clinical response and the resolution of sepsis. Laboratory studies, including complete blood count, erythrocyte sedimentation rate, C-reactive protein can be followed to assess response to therapy, but the clinical significance of these and their role in prognosis have not been clearly demonstrated in the literature.
Because of the low incidence of occurrence, no randomized controlled trials of the benefits of anticoagulation exist. Furthermore, evidence is lacking for recommendations on the optimal method of anticoagulation and duration of therapy, though 3 months is the current default duration. 17, 18 Decisions are generally made on a case-by-case basis, with consideration of any contraindications to anticoagulation, risks for bleeding, response to initial antibiotic treatment, risk of complications, and estimated likelihood of thrombus progression or septic emboli. Follow-up CT is done at 1-to 3-month intervals to reevaluate thrombus progression, occurrence of septic emboli, and further need for anticoagulation.
Surgical involvement is usually a last step in the process. Surgery may be indicated for complications of Lemierre syndrome, such as loculated empyemas, brain abscesses, pulmonary abscesses, retropharyngeal abscesses, or other adverse sequelae. Ligation of the IJ vein was a more common practice in the past, but this is rarely performed now. Thrombi that do not extend into the skull generally do not require surgery. Trials of appropriate antibiotic therapy and anticoagulation is the first line of treatment. If no clinical improvement occurs with medical management, then surgery becomes a consideration.
Conclusions and Recommendations
Lemierre syndrome is a rare disease that requires a high index of clinical suspicion. While it is also known as the "forgotten disease," considering it in a differential diagnosis is crucial because of its high association with serious complications. Prompt diagnosis with early initiation of appropriate treatment is crucial in preventing severe morbidity and mortality. Because of its rarity, specific guidelines and evidence for optimal management do not exist. Antibiotic management should start with broadspectrum coverage that is further guided by immediate blood cultures and CT of the neck and other affected parts, such as the head and chest. Minimal therapy seems to include at least 2 to 4 weeks of IV antibiotics followed by another 2 to 4 weeks of oral therapy. Anticoagulation plays a controversial and undefined role in treatment. In light of the serious adverse sequelae of the disease, anticoagulation should be strongly considered in patients with no contraindications or increased risk of bleeding, especially those already demonstrating poor response to appropriate treatment or evidence of septic emboli. The optimal anticoagulation method should be bridge therapy with heparin and the use of warfarin for 3 months. Evaluation of thrombophilias may be indicated, but its clinical benefit is uncertain.
The optimal anticoagulation method, duration of therapy, and duration of follow-up for reimaging is not well defined. Evaluation of thrombophilias may be indicated, but its clinical benefit is uncertain. Because of the lack of evidence to support guidance of management, patients are generally managed on a case-by-case basis, with close monitoring for clinical improvement or adverse sequelae.
